A Photoactivatable Platinum(IV) Complex Targeting Genomic DNA and Histone Deacetylases

We report toxic effects of a photoactivatable platinum(IV) complex conjugated with suberoyl‐bis‐hydroxamic acid in tumor cells. The conjugate exerts, after photoactivation, two functions: activity as both a platinum(II) anticancer drug and histone deacetylase (HDAC) inhibitor in cancer cells. This a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Angewandte Chemie International Edition 2015-11, Vol.54 (48), p.14478-14482
Hauptverfasser: Kasparkova, Jana, Kostrhunova, Hana, Novakova, Olga, Křikavová, Radka, Vančo, Ján, Trávníček, Zdeněk, Brabec, Viktor
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 14482
container_issue 48
container_start_page 14478
container_title Angewandte Chemie International Edition
container_volume 54
creator Kasparkova, Jana
Kostrhunova, Hana
Novakova, Olga
Křikavová, Radka
Vančo, Ján
Trávníček, Zdeněk
Brabec, Viktor
description We report toxic effects of a photoactivatable platinum(IV) complex conjugated with suberoyl‐bis‐hydroxamic acid in tumor cells. The conjugate exerts, after photoactivation, two functions: activity as both a platinum(II) anticancer drug and histone deacetylase (HDAC) inhibitor in cancer cells. This approach relies on the use of a PtIV pro‐drug, acting by two independent mechanisms of biological action in a cooperative manner, which can be selectively photoactivated to a cytotoxic species in and around a tumor, thereby increasing selectivity towards cancer cells. These results suggest that this strategy is a valuable route to design new platinum agents with higher efficacy for photodynamic anticancer chemotherapy. Two‐in‐one platinum anticancer drugs: The strategies based on simultaneous inhibition of histone deacetylases and DNA damage by platinum drugs induced by light may result in efficient antitumor activity taking advantages of selective and targeted activation in tumor cells.
doi_str_mv 10.1002/anie.201506533
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1776658823</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2562137308</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5423-4e465b07c84e36372a4513750c178c788b7b548caac9120cb3e0346f5db7134d3</originalsourceid><addsrcrecordid>eNqFkUtvEzEURi0EoiWwZYkssSmLCbavX11GacmDKnRRytLyODdlysw4Hc9A8-9xSYkQC1j5yjrfZ-seQl5zNuaMife-rXAsGFdMK4An5JgrwQswBp7mWQIUxip-RF6kdJt5a5l-To6ElipP9phcT-jl19hHH_rqu-99WSO9rH1ftUNzsrh-R6ex2dZ4T698d4P5-obOsI1NFejZakJ9u6bzKvWxRXqGPmC_q33C9JI82_g64avHc0Q-fzi_ms6Li0-zxXRyUQQlBRQSpVYlM8FKBA1GeKk4GMUCNzYYa0tTKmmD9-GUCxZKQAZSb9S6NBzkGkbkZN-77eLdgKl3TZUC1rVvMQ7JcWO0VtYKyOjbv9DbOHRt_p0TSov8LDD7L4rnKmF-7XlExnsqdDGlDjdu21WN73aOM_fgxT14cQcvOfDmsXYoG1wf8N8iMnC6B35UNe7-U-cmq8X5n-XFPptF4P0h67tvTpu8TfdlNXPLuVlOOV-6j_ATdjqlJA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1766270653</pqid></control><display><type>article</type><title>A Photoactivatable Platinum(IV) Complex Targeting Genomic DNA and Histone Deacetylases</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Kasparkova, Jana ; Kostrhunova, Hana ; Novakova, Olga ; Křikavová, Radka ; Vančo, Ján ; Trávníček, Zdeněk ; Brabec, Viktor</creator><creatorcontrib>Kasparkova, Jana ; Kostrhunova, Hana ; Novakova, Olga ; Křikavová, Radka ; Vančo, Ján ; Trávníček, Zdeněk ; Brabec, Viktor</creatorcontrib><description>We report toxic effects of a photoactivatable platinum(IV) complex conjugated with suberoyl‐bis‐hydroxamic acid in tumor cells. The conjugate exerts, after photoactivation, two functions: activity as both a platinum(II) anticancer drug and histone deacetylase (HDAC) inhibitor in cancer cells. This approach relies on the use of a PtIV pro‐drug, acting by two independent mechanisms of biological action in a cooperative manner, which can be selectively photoactivated to a cytotoxic species in and around a tumor, thereby increasing selectivity towards cancer cells. These results suggest that this strategy is a valuable route to design new platinum agents with higher efficacy for photodynamic anticancer chemotherapy. Two‐in‐one platinum anticancer drugs: The strategies based on simultaneous inhibition of histone deacetylases and DNA damage by platinum drugs induced by light may result in efficient antitumor activity taking advantages of selective and targeted activation in tumor cells.</description><edition>International ed. in English</edition><identifier>ISSN: 1433-7851</identifier><identifier>EISSN: 1521-3773</identifier><identifier>DOI: 10.1002/anie.201506533</identifier><identifier>PMID: 26458068</identifier><identifier>CODEN: ACIEAY</identifier><language>eng</language><publisher>Weinheim: WILEY-VCH Verlag</publisher><subject>Anticancer properties ; Antitumor agents ; Cancer ; Chemotherapy ; Cytotoxicity ; Deoxyribonucleic acid ; DNA ; DNA - chemistry ; Genes ; Genome ; Histone deacetylase ; histone deacetylase inhibitors ; Histone Deacetylases - metabolism ; Histones ; Hydroxamic acid ; Photoactivation ; Photochemistry ; Platinum ; Platinum - chemistry ; platinum prodrugs ; Selectivity ; Toxicity ; Tumor cells ; Tumors</subject><ispartof>Angewandte Chemie International Edition, 2015-11, Vol.54 (48), p.14478-14482</ispartof><rights>2015 WILEY‐VCH Verlag GmbH &amp; Co. KGaA, Weinheim</rights><rights>2015 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</rights><rights>2015 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim</rights><rights>Copyright Wiley Subscription Services, Inc. Nov 2015</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5423-4e465b07c84e36372a4513750c178c788b7b548caac9120cb3e0346f5db7134d3</citedby><cites>FETCH-LOGICAL-c5423-4e465b07c84e36372a4513750c178c788b7b548caac9120cb3e0346f5db7134d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fanie.201506533$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fanie.201506533$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26458068$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kasparkova, Jana</creatorcontrib><creatorcontrib>Kostrhunova, Hana</creatorcontrib><creatorcontrib>Novakova, Olga</creatorcontrib><creatorcontrib>Křikavová, Radka</creatorcontrib><creatorcontrib>Vančo, Ján</creatorcontrib><creatorcontrib>Trávníček, Zdeněk</creatorcontrib><creatorcontrib>Brabec, Viktor</creatorcontrib><title>A Photoactivatable Platinum(IV) Complex Targeting Genomic DNA and Histone Deacetylases</title><title>Angewandte Chemie International Edition</title><addtitle>Angew. Chem. Int. Ed</addtitle><description>We report toxic effects of a photoactivatable platinum(IV) complex conjugated with suberoyl‐bis‐hydroxamic acid in tumor cells. The conjugate exerts, after photoactivation, two functions: activity as both a platinum(II) anticancer drug and histone deacetylase (HDAC) inhibitor in cancer cells. This approach relies on the use of a PtIV pro‐drug, acting by two independent mechanisms of biological action in a cooperative manner, which can be selectively photoactivated to a cytotoxic species in and around a tumor, thereby increasing selectivity towards cancer cells. These results suggest that this strategy is a valuable route to design new platinum agents with higher efficacy for photodynamic anticancer chemotherapy. Two‐in‐one platinum anticancer drugs: The strategies based on simultaneous inhibition of histone deacetylases and DNA damage by platinum drugs induced by light may result in efficient antitumor activity taking advantages of selective and targeted activation in tumor cells.</description><subject>Anticancer properties</subject><subject>Antitumor agents</subject><subject>Cancer</subject><subject>Chemotherapy</subject><subject>Cytotoxicity</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>DNA - chemistry</subject><subject>Genes</subject><subject>Genome</subject><subject>Histone deacetylase</subject><subject>histone deacetylase inhibitors</subject><subject>Histone Deacetylases - metabolism</subject><subject>Histones</subject><subject>Hydroxamic acid</subject><subject>Photoactivation</subject><subject>Photochemistry</subject><subject>Platinum</subject><subject>Platinum - chemistry</subject><subject>platinum prodrugs</subject><subject>Selectivity</subject><subject>Toxicity</subject><subject>Tumor cells</subject><subject>Tumors</subject><issn>1433-7851</issn><issn>1521-3773</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUtvEzEURi0EoiWwZYkssSmLCbavX11GacmDKnRRytLyODdlysw4Hc9A8-9xSYkQC1j5yjrfZ-seQl5zNuaMife-rXAsGFdMK4An5JgrwQswBp7mWQIUxip-RF6kdJt5a5l-To6ElipP9phcT-jl19hHH_rqu-99WSO9rH1ftUNzsrh-R6ex2dZ4T698d4P5-obOsI1NFejZakJ9u6bzKvWxRXqGPmC_q33C9JI82_g64avHc0Q-fzi_ms6Li0-zxXRyUQQlBRQSpVYlM8FKBA1GeKk4GMUCNzYYa0tTKmmD9-GUCxZKQAZSb9S6NBzkGkbkZN-77eLdgKl3TZUC1rVvMQ7JcWO0VtYKyOjbv9DbOHRt_p0TSov8LDD7L4rnKmF-7XlExnsqdDGlDjdu21WN73aOM_fgxT14cQcvOfDmsXYoG1wf8N8iMnC6B35UNe7-U-cmq8X5n-XFPptF4P0h67tvTpu8TfdlNXPLuVlOOV-6j_ATdjqlJA</recordid><startdate>20151123</startdate><enddate>20151123</enddate><creator>Kasparkova, Jana</creator><creator>Kostrhunova, Hana</creator><creator>Novakova, Olga</creator><creator>Křikavová, Radka</creator><creator>Vančo, Ján</creator><creator>Trávníček, Zdeněk</creator><creator>Brabec, Viktor</creator><general>WILEY-VCH Verlag</general><general>WILEY‐VCH Verlag</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TM</scope><scope>K9.</scope></search><sort><creationdate>20151123</creationdate><title>A Photoactivatable Platinum(IV) Complex Targeting Genomic DNA and Histone Deacetylases</title><author>Kasparkova, Jana ; Kostrhunova, Hana ; Novakova, Olga ; Křikavová, Radka ; Vančo, Ján ; Trávníček, Zdeněk ; Brabec, Viktor</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5423-4e465b07c84e36372a4513750c178c788b7b548caac9120cb3e0346f5db7134d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Anticancer properties</topic><topic>Antitumor agents</topic><topic>Cancer</topic><topic>Chemotherapy</topic><topic>Cytotoxicity</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>DNA - chemistry</topic><topic>Genes</topic><topic>Genome</topic><topic>Histone deacetylase</topic><topic>histone deacetylase inhibitors</topic><topic>Histone Deacetylases - metabolism</topic><topic>Histones</topic><topic>Hydroxamic acid</topic><topic>Photoactivation</topic><topic>Photochemistry</topic><topic>Platinum</topic><topic>Platinum - chemistry</topic><topic>platinum prodrugs</topic><topic>Selectivity</topic><topic>Toxicity</topic><topic>Tumor cells</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kasparkova, Jana</creatorcontrib><creatorcontrib>Kostrhunova, Hana</creatorcontrib><creatorcontrib>Novakova, Olga</creatorcontrib><creatorcontrib>Křikavová, Radka</creatorcontrib><creatorcontrib>Vančo, Ján</creatorcontrib><creatorcontrib>Trávníček, Zdeněk</creatorcontrib><creatorcontrib>Brabec, Viktor</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Nucleic Acids Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><jtitle>Angewandte Chemie International Edition</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kasparkova, Jana</au><au>Kostrhunova, Hana</au><au>Novakova, Olga</au><au>Křikavová, Radka</au><au>Vančo, Ján</au><au>Trávníček, Zdeněk</au><au>Brabec, Viktor</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Photoactivatable Platinum(IV) Complex Targeting Genomic DNA and Histone Deacetylases</atitle><jtitle>Angewandte Chemie International Edition</jtitle><addtitle>Angew. Chem. Int. Ed</addtitle><date>2015-11-23</date><risdate>2015</risdate><volume>54</volume><issue>48</issue><spage>14478</spage><epage>14482</epage><pages>14478-14482</pages><issn>1433-7851</issn><eissn>1521-3773</eissn><coden>ACIEAY</coden><abstract>We report toxic effects of a photoactivatable platinum(IV) complex conjugated with suberoyl‐bis‐hydroxamic acid in tumor cells. The conjugate exerts, after photoactivation, two functions: activity as both a platinum(II) anticancer drug and histone deacetylase (HDAC) inhibitor in cancer cells. This approach relies on the use of a PtIV pro‐drug, acting by two independent mechanisms of biological action in a cooperative manner, which can be selectively photoactivated to a cytotoxic species in and around a tumor, thereby increasing selectivity towards cancer cells. These results suggest that this strategy is a valuable route to design new platinum agents with higher efficacy for photodynamic anticancer chemotherapy. Two‐in‐one platinum anticancer drugs: The strategies based on simultaneous inhibition of histone deacetylases and DNA damage by platinum drugs induced by light may result in efficient antitumor activity taking advantages of selective and targeted activation in tumor cells.</abstract><cop>Weinheim</cop><pub>WILEY-VCH Verlag</pub><pmid>26458068</pmid><doi>10.1002/anie.201506533</doi><tpages>5</tpages><edition>International ed. in English</edition></addata></record>
fulltext fulltext
identifier ISSN: 1433-7851
ispartof Angewandte Chemie International Edition, 2015-11, Vol.54 (48), p.14478-14482
issn 1433-7851
1521-3773
language eng
recordid cdi_proquest_miscellaneous_1776658823
source MEDLINE; Access via Wiley Online Library
subjects Anticancer properties
Antitumor agents
Cancer
Chemotherapy
Cytotoxicity
Deoxyribonucleic acid
DNA
DNA - chemistry
Genes
Genome
Histone deacetylase
histone deacetylase inhibitors
Histone Deacetylases - metabolism
Histones
Hydroxamic acid
Photoactivation
Photochemistry
Platinum
Platinum - chemistry
platinum prodrugs
Selectivity
Toxicity
Tumor cells
Tumors
title A Photoactivatable Platinum(IV) Complex Targeting Genomic DNA and Histone Deacetylases
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T18%3A12%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Photoactivatable%20Platinum(IV)%20Complex%20Targeting%20Genomic%20DNA%20and%20Histone%20Deacetylases&rft.jtitle=Angewandte%20Chemie%20International%20Edition&rft.au=Kasparkova,%20Jana&rft.date=2015-11-23&rft.volume=54&rft.issue=48&rft.spage=14478&rft.epage=14482&rft.pages=14478-14482&rft.issn=1433-7851&rft.eissn=1521-3773&rft.coden=ACIEAY&rft_id=info:doi/10.1002/anie.201506533&rft_dat=%3Cproquest_cross%3E2562137308%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1766270653&rft_id=info:pmid/26458068&rfr_iscdi=true